Avecia
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
33 Locke Dr, Marlborough, Massachusetts,...Phone Number
(508) 532-2500Website
www.avecia.comRevenue
$39.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About Avecia
Nitto Avecia specializes in comprehensive oligonucleotide solutions, offering services that range from preclinical manufacturing to drug substance manufacturing. With over 25 years of experience, they provide analytical development, process development, and quality control services tailored for the pharmaceutical industry. Their intended clients include companies involved in oligonucleotide programs seeking robust and cost-effective manufacturing processes. Nitto Avecia is committed to quality assurance and technological innovation in the biopharmaceutical sector.Explore more
Avecia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avecia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Avecia launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Avecia is spiking on competitors!
Funding: Get notified immidiatlly once Avecia has new funding data
Avecia, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Avecia
Click to see if Avecia had a recent Job posting/layoffs
Check if Avecia has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Avecia recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Avecia
Compare insights from companies similar to Avecia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avecia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avecia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avecia.
Avecia Tech Stack
A closer look at the technologies used by Avecia
Most Recent Scoops
Hiring Plans
Avecia has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Engineering Drawings, Continuous Improvement Process, Manufacturing Operations, Engineering Research, Process Engineering, Engineering Documentation, and Electrical Engineering.
Hiring Plans
Open Position
Open Position
Event
Product Marketing, Events, Sales, Compliance, Logistics / Supply Chain, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Open Position
Avecia News & Media
n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases
SAN DIEGO--(BUSINESS WIRE)-- #ASO--n-Lorem Foundation, a nonprofit organization that provides free, lifetime supplies of individualized RNA-targeted medicines to patients with ultra-rare diseases, today announced a new partnership with Nitto Avecia, the world’s largest oligonucleotide therapeutics manufacturer. n-Lorem Foundation is the first and only charitable organization with a mission to provide personalized and potentially life-saving treatments to patients who have diseases caused by extrNitto Strengthens Oligonucleotide Therapeutic Manufacturing Business
OSAKA, Japan--(BUSINESS WIRE)--In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation (Headquarters: Osaka; President: Hideo Takasaki; referred to hereafter as “Nitto”) will invest approximately 25 billion Japanese yen in Nitto Denko Avecia Inc. (Headquarters: Massachusetts, USA; referred to hereafter as “Avecia”), a subsidiary of Nitto, and other related business establishments and groNautic Partners buys Mikart
Nautic Partners has closed its buy of Mikart Inc. Financial terms weren’t announced. Mikart, of Atlanta, is a contract development and manufacturing organization for the development, manufacturing and packaging of solid dose and non-sterile liquid pharmaceuticals. Michael Kallelis was named CEO of the company.Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis Appointed as CEO
PROVIDENCE, R.I. & ATLANTA--(BUSINESS WIRE)--Nautic Partners Announces Acquisition of Mikart
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avecia
Sign Up For FreeTo access detailed company insights
Nitto Avecia specializes in comprehensive oligonucleotide solutions, offering services that range from preclinical manufacturing to drug substance manufacturing. With over 25 years of experience, they provide analytical development, process development, and quality control services tailored for the pharmaceutical industry. Their intended clients in... Read More
